Diabetes

Papers
(The TQCC of Diabetes is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
352-OR: Regulation of Melanocortin Receptor 4 (MC4R) Ciliary Trafficking168
983-P: Long-Term Improvement in CGM-Measured Glycemic Control in Adults with Type 2 Diabetes Not Treated with Insulin—Real-World Data95
1082-P: Online Clinician Education Results in Performance Changes in Clinical Practice Related to Obesity Management in Patients With and Without Type 2 Diabetes89
1465-P: Identification of GCK Gene Variants and Clinical Characterization in Japanese Pediatric MODY2 Cases79
661-P: Use of a Sequential Continuous Glucose Monitoring with or without Exercise Tracker on Glycaemic Control in Middle-Aged Patients with Diabetes Mellitus75
2054-LB: Mitigating Adipose Tissue Dysfunction and Insulin Resistance in Obesity via SVEP1 Peptide-Mediated Suppression of Adipose Tissue Macrophage-Induced Inflammation71
1081-P: Trends in Treatment Goal Attainment of Cardiovascular Risk Factors in Chilean Adults with Diabetes Mellitus—Results from the National Health Survey 2016–201770
141-LB: Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (rt-CGM) vs. Intermittent-Scanning Continuous Glucose Monitoring (is-CGM) from a U.S. Payer Perspective in Patients with Type 2 Di70
1708-P: Development of a Needle-Free, Self-Applied Microarray Patch for GLP-1 Delivery64
1682-P: Factors Associated with Postprandial Suppression of Endogenous Glucose Production in People without Diabetes64
71-OR: ADA Presidents' Select Abstract: HLA-Focused Meta-Genetic Risk Score (GRS) Performance in Populations of Diverse Ancestry with Type 1 Diabetes62
880-P: Effects of Energy Dosing on Safety and Efficacy in an Open-Label Study of Endoscopic Pulsed Electric Field Induced Electroporation in Type 2 Diabetes (REGENT-1 Trial)61
574-P: Meta-analysis Shows Mind- and Body-Based Interventions Improve Glycemic Control in Patients with Type 2 Diabetes59
1478-P: Polygenic Risk Score Predicts Incident Cardiovascular Disease in People with Diabetes at Borderline or Intermediate 10-Year ASCVD Risk57
249-OR: Cystatin C Predicts Cardiovascular Events in Patients with Coronary Artery Disease Both among Patients with and among Those without Type 2 Diabetes57
2037-LB: Considerations for Calculating and Reporting CGM Wear-Time in Research Settings54
468-P: Association between Sudomotor Function and Coronary Atherosclerosis in Patients with Type 2 Diabetes48
1638-P: Oxidized Lipids Cause Ceramide Accumulation and Insulin Resistance in Skeletal Muscle46
261-OR: Validation of Mitraa, a GPT-Based Conversational Model for Enhancing Diabetes Self-Management and Education45
1034-P: No “Honeymoon” for Youth, in Particular Blacks, Diagnosed with Diabetes during the First Year of the COVID-Pandemic44
1740-P: Regulation of Endocrine Cell Alternative Splicing Revealed by Single-Cell RNA Sequencing in Type 2 Diabetes43
921-P: Impact of Heart Rate and Step Count on Deep Learning Glucose Prediction Models during Physical Activity42
1078-P: Elderly Patient with DM2 during the COVID-Pandemia: Forgotten but Good Glycemic Control42
1451-P: Peri-Islet Fibrosis in Cystic Fibrosis Is Associated with Altered Alpha-Cell Phenotype38
68-OR: Influence of the Type 1 Diabetes Genetic Risk Score on Response to Immunotherapies for Type 1 Diabetes Prevention38
697-P: Evaluation of Acceptance and Commitment Therapy on Glycemic Control in Type 2 Diabetes Patients38
171-LB: Estimating the Immunological Risk for Type 1 Diabetes from a CGM-Based One Week Self-Administered Home Test37
1591-P: Effects of Light Exposure during Sleep on Glycemic Control in Type 1 Diabetes37
1558-P: Immunological Role of Hybrid Insulin Peptide in Type 1 Diabetes in Asia37
727-P: A New HbA1c Test Based on a Cellular Stiffness Measurement of Red Blood Cells37
240-OR: Quantifying Glucose Utilization and Endogenous Glucose Production during Resistance Exercise in People with Type 1 Diabetes (T1D)36
1586-P: Association between PCSK7 Levels and NAFLD Severity in KADEM Study35
478-P: Application of Plasma Proteomics to Explore Potential Biomarkers of Diabetic Macular Edema34
280-OR: Insulin Sensitivity following an In-Home Sleep and Circadian Intervention for Habitually Short-Sleeping Adolescents34
252-OR: Maternal Obesity and Diabetes during Pregnancy and Quantitative Checklist for Autism in Toddlers (QCHAT) Scores in Offspring34
562-P: A Social Media Intervention Shows Promise to Improve Health Outcomes in Low-Income Immigrants with Type 2 Diabetes—Evidence from a Pilot RCT33
633-P: Insight to the Association between Serum Fibroblast Growth Factor 23 Levels and Presarcopenia in Nondiabetic Individuals—A Longitudinal Cohort Study33
718-P: A High FODMAP Diet Reduces Glycemic Excursion without Increasing Gastrointestinal Symptoms in Individuals with Prediabetes Treated with Metformin—A Randomized Crossover Controlled-Feeding Trial32
1641-P: Effect of Specific Weight-Reducing Interventions on Metabolic and Immunological Outcomes in Mice32
1358-P: Diabetes Prediction without Blood Tests—The Role of Retinal Imaging and Artificial Intelligence32
179-OR: Improved A1C and TIR with Once-Weekly Insulin Icodec vs. Insulin Glargine U100 in Insulin-Naïve T2D—ONWARDS 132
58-LB: Antidiabetic Effects of Pediococcus acidilactici pA1c on HFD-Induced Mice31
99-OR: AgRP Neuron Hyperactivity Drives Hyperglycemia in a Mouse Model of Type 2 Diabetes31
366-P: Machine Learning Reveals CGM Superiority over Hypoglycemia Awareness Questionnaires in Discriminating Individuals with Severe Hypoglycemia31
643-P: Exploring Eating Styles of Older Adults with Type 1 Diabetes (T1D)31
1478-P: Incidence and Glucose Trends among Patients with Acute Stroke and Stress Hyperglycemia—Insights from a Descriptive Analysis31
609-P: Virtual Peer Groups (VPG) for Adolescents and Young Adults (AYA) with Type 1 Diabetes (T1D) : Patient-Reported Importance of Specific Features30
967-P: The Use of Hybrid Closed-Loop Insulin Delivery in Adolescents and Young Adults with High-Risk Acute Lymphoblastic Leukemia during Induction Chemotherapy30
1667-P: Mesenteric Visceral Lipectomy (MVL) Improves Glucose Tolerance in Patients with Type 2 Diabetes (T2D)29
30-OR: Effects of Vitamin D Supplementation by Race and Weight Status on Serum Vitamin D Measures and Diabetes Risk in the D2d Study29
121-OR: Safety, Tolerability, and Metabolic Effects of Once-Weekly GL0034 (Utreglutide) in Individuals with Obesity—A Multiple Ascending Dose Study28
1823-LB: DiaLOG—A Personalized and Interactive Diabetes Education Platform Empowered with Risk Assessment AI Algorithms and ChatGPT28
500-P: Causal Effect of SGLT2 Inhibition on Diabetes-Related Retinopathy (DR) and Macular Edema (DME)28
527-P: Needs of mHealth Diabetes Services from Patients with Poorly Controlled Type 2 Diabetes Mellitus: A Qualitative Study27
649-P: Preliminary Outcomes of a Transition Intervention with Adolescents and Young Adults (AYAs) with Type 1 Diabetes (T1D)27
255-LB: Defining Functional Phenotype in Human Islets across Endocrine Cell Composition, Donor Age, Sex, and Ancestry27
102-OR: Association of Elevated Arterial Stiffness with Cardiac Target Organ Damage in Young Adults with Diabetes: The Search for Diabetes in Youth Study27
1127-P: Diabetes Risk in Marginalized Urban Settings in Mexico City27
1635-P: Sex Differences in Skeletal Muscle Mitochondrial Function in Rats Fed a High-Fat/High-Sucrose Diet27
248-OR: Diabetes Remission after Gastric Bypass Is Characterized by Upregulation of LXR and Antioxidant-Related Pathways in Jejunum26
105-OR: Single-Cell Multiomic Analysis of the Effect of GIP and GIP-1 Mono- and Multi-agonism on the Hypothalamus and Hindbrain26
431-P: Effects of CB1 Antagonist INV-202 in Patients with Metabolic Syndrome—A Randomized, Placebo-Controlled, Double-Blind Phase 1B Study26
111-OR: Vascular Endothelium-Specific ROCK2 Deficiency Inhibits the Progression of Obesity via Adipocyte Browning26
1268-P: P-tau217 and Cognitive Function in Long-Duration Type 1 Diabetes26
264-OR: Incorporating Shared Decision-Making to Facilitate Equitable Insulin Pump Use among Pediatric Patients with Type 1 Diabetes26
261-LB: Hepatocyte Gdf15 Protects against CCL4-Induced Liver Injury Independent of Changes in Feeding and Inflammation26
475-P: Intermittent Hypoxia Increased the Expression of Intercellular Adhesion Molecule-1 and Endothelial Cell–Specific Molecule-1 in Vascular Endothelial Cells via the Downregulation of MicroRNA-181a25
603-P: Diabetes Distress Is Associated with Poor Glycemic Control after Islet Autotransplantation25
1278-P: Changes in Cardiovascular Disease (CVD) Incidence Due to Remission of Diabetes and Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD)25
531-P: Continuous Glucose Monitoring Placement during Physical Activity25
1720-P: Epigenetic Regulator Slug Directly Promotes Beige Adipogenesis25
1190-P: Oral Health Status among U.S. Adults with and without Diabetes, 202025
1117-P: Comparison between Glucose Management Indicator (GMI) with HbA1c among Patients in a Hybrid Therapeutics Care Model25
55-LB: Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2DM and NGT Subjects24
213-LB: Combined Oral Contraceptives Drive Inactivity and Hepatic Mitochondrial Oxidative Stress in Female Mice24
1616-P: MENTSH—A Mitochondrial Microprotein and SNP-Associated with Diabetes in People with Native American Ancestry24
1574-P: FoxO1 Links Insulin Resistance to Hepatic Inflammation and Catalyzes the Evolution of Benign Steatosis to Nonalcoholic Steatohepatitis23
1687-P: Similarities and Differences between Metabolically Unhealthy Lean and Metabolically Unhealthy Obese Individuals23
1811-PUB: Real-World Safety of the Combined Use of Dapagliflozin and Metformin in Type 2 Diabetes Mellitus Patients in China—Post Hoc Analysis of the DONATE Study23
1387-P: Impacts of Androgen-Deprivation Therapy on Glucose Metabolism23
1117-P: Variability in Glycemia Measured by CGM in Children and Young Adults with Acute Recurrent or Chronic Pancreatitis23
160-LB: Age-Related Adipose Tissue Fibrosis and Neuropathy in the Genetically Diverse HET3 Mouse23
201-LB: Benefit of Dual Therapy with GLP-1 RA and SGLT2i on Renal Outcomes in Type 2 Diabetes22
546-P: Comparing Diabetes Risk Perception between Latina and White Women with T2D Risk Factors22
1463-P: Heterozygous Variant in NFKB1 Presenting with Autoantibody-Negative (AbNeg) Insulin-Dependent Diabetes (IDDM)22
134-OR: NOD1 Deletion in Skeletal Muscle Protects against Palmitate-Induced Insulin Resistance22
11-PUB: Transitioning from Dulaglutide to Tirzepatide Improves Glycemic Control in Patients Undergoing Hemodialysis with Type 2 Diabetes—An Assessment by Continuous Glucose Monitoring22
1416-P: Differences in Treatment and Metabolic Outcome between Males and Females Living with T2D—Results from the Multicenter DPV Registry22
217-LB: Heterogeneity of Single Cells Obtained from Peripheral Blood Mononuclear Cells Collected from Youth with Recent-Onset Type 1 Diabetes22
74-PUB: Knowledge, Attitude, and Practice of Individuals with Obesity—Insights from a Large Nationwide Survey22
1792-LB: Long-Term Impact of Glucose Status on Risk of Restenosis after Percutaneous Transluminal Coronary Angioplasty—A Six-Year Follow-up Study22
438-P: Very-Low-Dose Metformin Can Safely Improve Glycemic Control in Type 2 Diabetic Patients Receiving Maintenance Hemodialysis (HD)21
1410-P: Impacts of COVID-19 on Underserved Communities with Diabetes21
389-P: A Six-Month Periodic Fasting Reduces Microalbuminuria and Improves Metabolic Control in Patients with Type 2 Diabetes and Diabetic Nephropathy: A Randomized Controlled Study21
1101-P: Patient-Centered Weight Management Clinical Decision Support—A Proof-of-Concept Study21
1499-P: Diabetes Technology Use and Acute Complications in Type 1 Diabetes—Racial Disparities Still Persist21
665-P: Association between Housing Insecurity and Hemoglobin A1c among Adults with Type 2 Diabetes—A Cross-Sectional Analysis of the All of Us Research Program21
410-P: Development and Validation of a Risk Score for Predicting the Initiation of Dialysis in People with and without Diabetes Mellitus21
437-P: Coronary Calcium Score and Cardiovascular Events in Ketosis-Prone Diabetes Compared with T2DM20
750-P: Association of Glucagon-Like Peptide 1 Receptor Agonists with Incident Parkinson’s Disease in U.S. Older Adults with Type 2 Diabetes20
1821-PUB: Relationship between Time in Range and Glucose Management Indicator in Adolescents and Children with Type 1 Diabetes Mellitus20
75-PUB: The Sartorius Fat Fraction Is Independently Associated with Myocardial Fibrosis in Chinese Patients with Obesity20
1044-P: Advancing Quality Improvement Culture among 27 Pediatric and Adult Diabetes Centers20
1692-P: Metabolic Assessment of Semaglutide (a GLP-1R Agonist) and Tirzepatide (a GLP-1R/GIPR Coagonist) in Diet-Induced Obese (DIO) Mice20
721-P: Mechanisms of Relapse after Lifestyle Intervention–Induced Remission of Prediabetes20
1767-P: Body Composition and Body Mass Index among People with and without Diabetes—A National Analysis, 2011–201819
1899-LB: The Predictors and Management of Eating Disorders in Adult Patients with Type 1 Diabetes Mellitus19
658-P: Evaluating Financial Incentives as a Tool to Increase Medication Adherence—A Systematic Review and Meta-analysis19
1893-LB: Effects of High Fibers and Probiotics Supplements Diet and Lifestyle Intervention in Type 2 Diabetes or Prediabetes—A Randomized, Double-Blind, Placebo-Controlled Pilot Trial19
1804-LB: Serum Spexin Level Is Negatively Associated with Peripheral Neuropathy and Sensory Pain in Type 2 Diabetes18
978-P: Correlation between Continuous Glucose Monitoring Metrics, Oral Glucose Tolerance Test, and HbA1c in Individuals with Impaired Glucose Tolerance18
1998-LB: Previously Frozen Beta-Cell Transcriptional Response to Cytokine Treatment Mirrors That of Fresh Beta Cells18
1928-LB: Understanding the Burden of Digital Care—Field Testing the TBQ+D in Patients Living with Diabetes18
1797-LB: Detection of Potential Therapeutic Target Associated with Coronary Artery Disease in Type 2 Diabetes Patients—System Biology Approach18
1041-P: Assessing the Value of Managing Diabetic Kidney Disease from a U.S. Health Care Perspective18
1777-P: Three-Dimensional Imaging Reveals Pancreatic Islet Fast Calcium Wave Origin Formation18
19-OR: Monitoring Stage 2 to Stage 3 Transition in Type 1 Diabetes Using Continuous Glucose Monitoring (CGM)18
18-OR: Discontinuation of Renin Angiotensin System Inhibitor and Cardiovascular-Renal Events in Advanced Diabetic Kidney Disease18
600-P: The Healthy Gut Diet for Preventing Gestational Diabetes Improves Dietary Intake and Diet Quality18
391-P: Targeted Deletion of Rho-Associated Coiled-Coil–Containing Protein Kinase 2 in Kidney Tubules Suppresses Expression and Function of Mineralocorticoid Receptor in Mice17
842-P: Improvement in Time in Range after Smart Insulin Pen Initiation in Austria17
495-P: Fully Immersive Virtual Reality Improves Empathy towards People with Diabetes17
Expression of Concern. Shuangxi Wang, Jian Xu, Ping Song, Benoit Viollet, and Ming-Hui Zou. In Vivo Activation of AMP-Activated Protein Kinase Attenuates Diabetes-Enhanced Degradation of GTP Cyclohydr17
Comparison of β-Cell Function and Insulin Sensitivity Between Normal-Weight and Obese Chinese With Young-Onset Type 2 Diabetes17
1764-P: Assessing Gene Expression Profile and Insulin Secretion in Human Beta Cells (EndoC-BH3) under Glucose Exposure17
252-OR: Associations of Serum Lipid Profiles with Diabetic Macular Edema and Retinal Structural Alterations17
507-P: Trajectories of Inflammatory Proteins over Diabetic Wound Healing Course17
946-P: Multicenter Quality Improvement Project: Increasing Depression Screening across Six Pediatric Endocrinology Centers in the U.S.17
63-PUB: Diabetes Control and Complications in South India—Three-Year Results of LANDMARC Trial17
Comment on Carrasco et al. Spatial Environment Affects HNF4A Mutation-Specific Proteome Signatures and Cellular Morphology in hiPSC-Derived β-Like Cells. Diabetes 2022;71:862–86917
Higher HbA1c Is Associated With Greater 2-Year Progression of White Matter Hyperintensities17
2101-LB: Recruitment Strategies to Increase the Reach of the National Diabetes Prevention Program in Rural Populations17
1435-P: Improvements in Metabolic Health from Spanish-Delivered Care Are Similar to English-Delivered Care in a Carbohydrate-Restricted Nutrition Therapy Program17
422-P: Type 2 Diabetes and the Individual Perception of Risk for Cardiovascular Death in Coronary Artery Disease Patients17
783-P: Elucidating the Benefit of Pump-Delivered Subcutaneous GLP-1R Agonist—Exploratory Study in the DIO Mouse17
827-P: Patient-Reported Outcomes with Use of Inhaled Technosphere Insulin (TI)17
Unveiling Novel Markers and Modeling Clinical Prediction of Treatment Effects Are Equally Important for Implementing Precision Therapeutics17
1801-LB: Discovering Novel Cathepsin L Inhibitors Using Artificial Intelligence for Diabetic Nephropathy17
594-P: Exercise Timing Has Limited Effect on Glycemic Profile in a Cluster of Well-Controlled Youth with Type 1 Diabetes16
1148-P: Risk Factor Control and Risk of Hospitalization for Heart Failure in Diabetic Patients16
933-P: Effects of Dapagliflozin and Metformin on Vascular Function in Newly Diagnosed Type 2 Diabetes—A Randomized Controlled Trial (DMVascular Study)16
1422-P: Understanding COVID-19 Impacts among Underserved Adults with Diabetes Using the Social-Ecological Model16
1301-P: The Effect of Insulin on α-Aminoadipic Acid Metabolism in Polycystic Ovary Syndrome (PCOS) Patients with Insulin Resistance16
280-LB: Efficacy of a Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults with Preexisting Medical Conditions16
1066-P: Sleep Habits and Their Impact on CGM Parameters in Patients with Type 1 Diabetes16
770-P: Efficacy and Safety of Tirzepatide in Participants Who Achieved Fasting Serum Glucose Targets at 52 Weeks in SURPASS-3 and SURPASS-416
612-P: The Effectiveness of Lifestyle, Metformin, or Dietary Supplements for the Prevention of Gestational Diabetes Mellitus (GDM) by Participant Characteristics—A Systematic Review and Meta-analysis16
150-LB: Diabetes and School Health (DASH) Program—An Innovative School-Based Health Model to Optimize Care for Youth with Type 1 Diabetes16
258-OR: Sustainability of HbA1c Control of Tirzepatide vs. Insulin Glargine in People with Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)16
Loss of Glomerular Permselectivity in Type 2 Diabetes Associates With Progression to Kidney Failure16
46-OR: Amelioration of Insulin Resistance after Delivery Lowers the Risk of Postpartum Type 2 Diabetes in Women with Gestational Diabetes Mellitus16
1844-LB: Community Engaged Research—Lessons Learned from a Pediatric Type 1 Diabetes Study16
385-P: MDSC-Mediated Neutrophil Extracellular Traps–Based Targeting of Diabetic Vasculopathy—Dapagliflozin for Vascular Remodeling in Diabetic Nephropathy16
1588-P: Translatable Modeling of Glucagon Actions in Human iPSC-Derived Hepatocytes Uniquely Predicts Differential Clinical Responses to Glucagon Analog Agonist Molecules16
1492-P: IL-8/CXCL8 May Identify a New Type 1 Diabetes Endotype16
932-P: MiniMed 780G System Use in a Real-World United States (U.S.) Population Aged 65 Years and Older with Diabetes15
571-P: Theory-Based Design of a Nutrition-Focused Approach at CGM Initiation for People with T2D15
118-OR: Fat Distribution Patterns Predict Type 2 Diabetes Risk and Provide Insights into Prediabetic Metabolism15
607-P: Associations of Gut Microbiome with Glycemic Control in a Carbohydrate-Restricted, High-Protein Diet for Type 2 Diabetes Mellitus15
79-OR: Targeted Erasure of DNA Methylation by TET3 with C/EBPδ Rewires Adipogenic Execution for Energy Metabolism15
1604-P: The Severity of Metabolic Dysfunction–Associated Steatohepatitis (MASH) Is Associated with Worse Hepatic Steatosis and Insulin Resistance15
1127-P: 4T Study—Early CGM Initiation and Tighter Glucose Targets Improves A1C in Youth with T1D15
999-P: Cost-Effectiveness of MiniMed 780G Therapy Compared with Multiple Daily Injections (MDI) with Intermittently Scanned Continuous Glucose Monitoring (isCGM) in People with Type 1 Diabetes (T1D)—A15
632-P: Beta-Cell Function Is a Stronger Predictor Than Insulin Resistance for Development of Type 2 Diabetes in Obese Indian Population—A Matched-Pair Cohort Analysis15
1137-P: Continuous Glucose Monitoring (CGM) Use and Its Impact on Glycemic Control and Acute Complications among Older-Onset Type 1 Diabetes Patients within the Veterans Health Administration (VHA)15
1571-P: Plasma FGF5 Concentration Correlates Better with Hepatic Steatosis, Blood Glucose, and Specific Plasma Free Fatty Acids than with Other Tissue Fat Accumulation15
1526-P: A Clinically Optimized Genetic Prediction Model for Differentiating Type 1 and Type 2 Diabetes15
1629-P: Association between Dyslipidemia and Myosteatosis Evaluated by Abdominal Computed Tomography15
1452-P: Financial Toxicity and Cost-Related Nonadherence (CRN) in Adults with Type 1 Diabetes (T1D)—Prevalence and Associations with Social Determinants of Health15
2188-LB: Associations between Alzheimer's Disease (AD) and Obesity—Clinical Trials of NA-813 for AD and NA-931 for Obesity15
727-P: A Phase 3 Evaluation of CAMP-Biased GLP-1 Analog Ecnoglutide vs. Dulaglutide in Adults with Type 2 Diabetes15
1706-P: Software-Aided Self Selection of Weight Loss Diet Plan for Facilitating Diabetes Management in Primary Care15
Lrtm1 - A Novel Sensor of Insulin Signaling and Regulator of Metabolism and Activity15
1397-P: A Cocoa Butter–Based Ketogenic Diet Fails to Improve Glucose Homeostasis and Promote Weight Loss in Obese Mice14
1022-P: Youth from High-Poverty Neighborhoods Demonstrate Higher HbA1c within Year after Diagnosis of T1D14
1713-P: Deletion of SGK1 in Smooth Muscle Cells Induces Adipose Tissue Beiging and Differential Secretion of Vasokines14
1635-P: Short-Term Production of Circulating Triglycerides Is Positively Associated with Triglyceride Concentration in Adolescents with and without MASLD14
227-LB: Kynurenine Pathway Is Associated with Preservation of Beta-Cell Function in Autoimmune Diabetes14
1726-P: Comparison of Subcutaneous, Visceral, Liver, and Muscle Fat Depots in Relation to Diabetes Risk—A Prospective Cohort Study14
1807-PUB: Monocarbonyl Curcumin Analogs C66 and B2BrBC Improve Redox Status in Streptozotocin-Induced Diabetic Rats14
429-P: The Difference between Cystatin C- and Creatinine-Based Estimated Glomerular Filtration Rate in Relation to Carotid Plaque Score in Patients with Type 2 Diabetes14
1223-P: Frequency and Predictors of Level 2 Time Above Range (TAR) in Older Adults with Type 2 Diabetes on Insulin Therapy—Data from the HYPOAGE Prospective Study14
1895-LB: Randomized Controlled Trial in a Real-World Setting Shows a Light Touch “Food Is Medicine” Program Improves Health Behaviors and Self-Reported Health Status in People with Diabetes14
1126-P: Smart Insulin Pens—A Randomized, Crossover Pilot Trial Assessing Glycemic Control and Diabetes-Related Burdens in Adolescents and Emerging Adults with Diabetes14
32-PUB: Glycemic Variability after Initiation of SGLT2 Inhibitors in CKD14
1040-P: Feasibility and Performance of Continuous Glucose Monitoring (CGM) to Guide Computerized Insulin Infusion Therapy in Cardiovascular Intensive Care Unit (CV-ICU)14
1762-P: Regional Body Fat Distribution Is Associated with Higher Risk for Sleep Deficiency and Sleep Disorders14
1908-LB: A Machine-Learning Framework to Quantify Postprandial Glucose Responses in Gestational Diabetes14
1707-P: Real-World 12-Month Weight Loss Outcomes of Tirzepatide—The Mayo Clinic Experience14
2060-LB: Benchmarking AI in Type 1 Diabetes Management—How Well Do Generative AI Platforms Follow ADA SOC?14
1661-P: Exogenous Oxytocin Has No Effect on Ad Libitum Food Intake or Postprandial Plasma Glucose Concentrations in Individuals with Obesity14
447-P: C/EBPß-Lin28a Positive Feedback Loop Mediated by C/EBPß Hypomethylation Promotes the Proliferation and Migration of Vascular Smooth Muscle Cells in Restenosis14
2176-LB: Circadian Clock Regulation of HIF1a-Dependent Skeletal Muscle Metabolism during Diet-Induced Obesity14
94-OR: Pathogenic Action of GAD65 Autoantibodies on Islet Function in Type 1 Diabetes14
2111-LB: Discrepancies between Creatinine-Cystatin C-Based and Creatinine-Based eGFR and Their Association with Vascular Complications in Adults With Diabetes—The China Diachronic Study14
1760-P: Mining Animal Venoms as a Source of Insulinotropic Peptides for Potential Diabetes Therapy14
1126-P: Does the Use of a Case Manager Matter in Diabetes Care?14
17-PUB: Glucagon-Like Peptide 1 Receptor Agonists' Heterogeneous Treatment Effects on Asthma Exacerbations—A Causal Machine-Learning Analysis14
726-P: Medication Adherence among American Indians with Type 2 Diabetes—Assessing the Quality of Electronic Health Record Data within a Large Tribal Health Care System14
283-OR: Adipose Stromal Cells Increase Insulin Sensitivity and Decrease Liver Gluconeogenesis in a Type 1 DM Mouse Model13
140-OR: Adoption of State-Level Complete Streets Legislations and U.S. Prevalence of Obesity13
1736-P: Exploring Intrinsic Features of Human Pancreatic a- and ß-Cell Physiology Using Pseudoislets13
72-OR: A Novel Multiancestry Polygenic Score Improves T1D Risk Prediction in Non-European Populations13
A 3-Week Ketogenic Diet Increases Skeletal Muscle Insulin Sensitivity in Individuals With Obesity: A Randomized Controlled Crossover Trial13
Adenylosuccinate Mediates Imeglimin-Induced Proliferative and Antiapoptotic Effects in β-Cells13
1-PUB: Impaired Kidney Function in Diabetic Patients—A Warning13
167-LB: Knowledge Retention and Glycemic Control in Participants of Kids in Control of Food (KICk OFF) Program—Virtual vs. On-Site13
1946-LB: Patterns of Insulin Discontinuation in Youth with New-Onset Type 2 Diabetes13
337-OR: Tirzepatide Improved Markers of Islet-Cell Function (Fasting Glucagon and HOMA2-B) and Insulin Sensitivity (Fasting Insulin and HOMA2-IR) Compared with Semaglutide in People with Type 2 Diabet13
218-OR: Time of Exercise Affects Nocturnal Hypoglycemia after Exercise in Adults with Type 1 Diabetes (T1D)—Results from the T1D Exercise Initiative (T1DEXI) Study13
204-OR: An Early Immune Signature in Prediabetes Can Predict Progression to Type 2 Diabetes13
2059-LB: NA-931, a Novel Triple IGF-1/GLP-1/GIP Incretin Receptor Agonist Reduces Body Weight and Improves Metabolic Profile in DIO Mice13
671-P: Development of Novel Infrastructure for Diabetes Distress Screening in the Electronic Health Record13
296-OR: Glucagon and Insulin Cross Talk Regulates Hepatic Glycogen Metabolism13
611-P: Do Social Needs Impact Quality of Life among Adult Medicaid Beneficiaries with Type 2 Diabetes?13
44-LB: Evaluating the Effectiveness of a Novel Form of Online Cognitive Behavioural Therapy for Patients with Type 2 Diabetes and Comorbid Anxiety or Depression13
785-P: Preclinical Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) Assessments of Sustained-Released Formulation of Once-Monthly Injectable Semaglutide (PT403)13
Of Mice and Men: Toward a Better Model of Diabetic Cardiomyopathy With Application in Female Animals13
Diabetes Genetic Clusters and Clinical Outcomes in American Indians13
238-OR: Changes In Renal Function after Islet Transplantation in a Single-Centre Cohort in Canada over 20 Years13
507-P: Human Liver-Specific Regulation of Lipogenesis by Long Noncoding RNA hLMR113
849-P: Antidiabetic Effects of TLC-3595, a Selective ACC2 Inhibitor, in ZDF Rats12
502-P: Increasing Provider Referrals to Diabetes Self-Management Education and Support Services: Recommendations from Virtual Focus Groups with Providers in New York State12
Polygenic Risk for Type 2 Diabetes in African Americans12
Perilipin 1 Antibodies in Patients With Acquired Generalized Lipodystrophy12
1849-LB: Social Determinants of Health and Early-Onset Type 2 Diabetes—A Qualitative Study12
Building the Glucagon-Like Peptide-1 Receptor Brick by Brick: Revisiting a 1993 Diabetes Classic by Thorens et al.12
Combined Weight Loss and Exercise Training Alters Skeletal Muscle Subcellular Lipid Localization and Intermuscular Adipose Tissue Cellular Composition12
75-LB: CT-388, a Novel Once-Weekly Dual GLP-1 and GIP Receptor Modulator, Is Safe, Well-Tolerated, and Produces More than 8% Weight Loss in Four Weeks in Overweight and Obese Adults12
10-LB: Activation of Sigma-1 Receptor as a Novel Therapeutic Target in Diabetic Kidney Disease12
Deficiency of the Hemoglobin-Haptoglobin Receptor, CD163, Worsens Insulin Sensitivity in Obese Male Mice12
Protein Markers of Diabetes Discovered in an African American Cohort12
Therapeutic Targets for Diabetic Kidney Disease: Proteome-Wide Mendelian Randomization and Colocalization Analyses12
Foxj3 Regulates Thermogenesis of Brown and Beige Fat Via Induction of PGC-1α12
1809-PUB: Painful Diabetic Neuropathy—Patients Treated with High-Frequency (10 kHz) Spinal Cord Stimulation (SCS) Experience Significant Reductions in A1C and Weight12
1051-P: Cost-Effectiveness of Flash CGM Compared with SMBG—A Canadian Private-Payer Perspective12
Upregulation of Acid-Sensing Ion Channel 1a in the Anterior Cingulate Cortex by TNF-α/NF-κB Pathway Contributes to Diabetes-Related Pain12
lncRNA-H19 in Fibroblasts Promotes Wound Healing in Diabetes12
Electrophysiological Characterization of Inducible Pluripotent Stem Cell–Derived Human β-Like Cells and an SLC30A8 Disease Model12
Protective Renalase Deficiency in β-Cells Shapes Immune Metabolism and Function in Autoimmune Diabetes12
High-Intensity Interval Training, Caloric Restriction, or Their Combination Have Beneficial Effects on Metabolically Acquired Peripheral Neuropathy12
Plasma Neuronal Growth Regulator 1 May Link Physical Activity to Reduced Risk of Type 2 Diabetes: A Proteome-Wide Study of ARIC Participants11
Dual Tracer Test to Measure Tissue-Specific Insulin Action in Individual Mice Identifies In Vivo Insulin Resistance Without Fasting Hyperinsulinemia11
Insulin Regulation of Lysine and α-Aminoadipic Acid Dynamics and Amino Metabolites in Women With and Without Insulin Resistance11
Erratum. Foxo1 Inhibits Diabetic Mucosal Wound Healing but Enhances Healing of Normoglycemic Wounds. Diabetes 2015;64:243–25611
Comment on Hu et al. Single-Cell Transcriptomics Reveals Novel Role of Microglia in Fibrovascular Membrane of Proliferative Diabetic Retinopathy. Diabetes 2022;71:762–77311
Comment on Baranova et al. Causal Associations Between Basal Metabolic Rate and COVID-19. Diabetes 2023;72:149–15411
A Randomized Controlled, Double-Masked, Crossover Study of a GPR119 Agonist on Glucagon Counterregulation During Hypoglycemia in Type 1 Diabetes11
Expression of Concern. Eduardo R. Ropelle, José R. Pauli, Dennys E. Cintra, Adelino S. da Silva, Cláudio T. De Souza, Dioze Guadagnini, Bruno M. Carvalho, Andrea M. Caricilli, Carlos K. Katashima, Mar11
34-OR: The Effect of Combined Activin A and Myostatin Blockade on Body Composition—A Phase 1 Trial11
0.84232687950134